<?xml version="1.0" encoding="UTF-8"?>
<p>Three vaccine candidates have been tested for MAYV. The first one was a formalin-inactivated vaccine with moderate efficiency in mice [
 <xref rid="B228-microorganisms-07-00133" ref-type="bibr">228</xref>]. More recently, a live attenuated vaccine and a DNA vaccine showed good immunogenicity and protection after a lethal challenge in mice [
 <xref rid="B229-microorganisms-07-00133" ref-type="bibr">229</xref>,
 <xref rid="B230-microorganisms-07-00133" ref-type="bibr">230</xref>].
</p>
